ArticleInternational journal of molecular sciences2026
CSDPCDA: A miRNA-Mediated Cross-Semantic Regulatory Network Framework for Predicting circRNA-Disease Associations.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
CircRNAs are emerging regulators of human diseases, often functioning through miRNA-mediated regulatory networks. However, experimentally validated circRNA-disease associations remain limited, hindering systematic investigation of circRNA functions and disease mechanisms. Here, we propose CSDPCDA, a miRNA-mediated cross-semantic regulatory network framework for predicting circRNA-disease associations by integrating multi-layer molecular information. CSDPCDA constructs a heterogeneous regulatory network incorporating circRNA-disease associations, circRNA-miRNA interactions, miRNA-disease associations, and molecular similarity information. Multiple biologically meaningful meta-paths are modeled to capture diverse regulatory patterns, and a cross-semantic attention mechanism is employed to integrate complementary molecular representations for association prediction. Comprehensive evaluations on the circR2Disease and circRNADisease datasets showed that CSDPCDA obtained higher AUC, AUPR, and F1-score than the representative existing methods under the same experimental settings. Ablation analyses demonstrated that incorporating miRNA-mediated regulatory information consistently improved the predictive performance across different datasets, while integrating complementary meta-path information further enhanced the characterization of complex molecular regulatory relationships. Moreover, case studies of breast cancer, colorectal cancer, and gastric cancer showed that many of the top-ranked predictions were consistent with previously reported disease-associated circRNAs, providing literature-based evidence for their potential biological relevance. CSDPCDA provides an interpretable framework for prioritizing potential disease-associated circRNAs and facilitating further biological investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.